🎙️Elevated Intel Special Edition - Federal Cannabis Rescheduling: What We Know (and What We Don’t) скачать в хорошем качестве

🎙️Elevated Intel Special Edition - Federal Cannabis Rescheduling: What We Know (and What We Don’t)

Federal cannabis rescheduling is making headlines — but what does it actually change? In this special edition of Elevated Intel, Jodi James and Cynthia Brewer break down the latest reports surrounding a potential executive order to move cannabis from Schedule I to Schedule III. They explain what rescheduling does and does not do, why nothing changes overnight, and what patients, businesses, and advocates should realistically expect next. From tax relief and research access to FDA, DEA, and pharmaceutical implications, this concise episode is designed to cut through speculation and keep the community informed — without panic, misinformation, or false celebration. 🌿⚖️ 00:00 – Welcome to the Special Edition 🎙️ 00:13 – Introducing Cynthia Brewer 🌿 00:27 – Why This Episode Exists ⚠️ 00:58 – Reports of a Rescheduling Executive Order 📜 01:38 – Cannabis Acknowledged as Medicine 🧠 02:34 – Rescheduling Does NOT Legalize or Decriminalize 🚫 02:58 – 280E Tax Relief & Plant-Touching Businesses 💰 03:29 – Research Access & Big Pharma Concerns 🔬 03:56 – Nothing Changes Overnight ⏳ 04:30 – States Control Their Own Programs 🗺️ 05:05 – No Cliff-Jumping Allowed 😅 05:44 – Opposition from Drug Free America & Testing Industry 🏛️ 06:02 – Schedule III Requirements Explained 📋 06:37 – FDA Approval & DEA Oversight 🧪 07:31 – Why Retail Cannabis Isn’t Becoming a Prescription Drug 🏥 08:14 – Devices, Genetics & Approval Complexity ⚙️ 08:40 – Florida’s Constitutional Medical Program 🛡️ 09:33 – Will Schedule III Help the Industry? 🤔 10:04 – Felony Fear & Worst-Case Scenarios ⚠️ 10:58 – Insurance, Pharma & Limited Use Cases 💊 11:40 – What FL CAN Is Watching For 👀 12:17 – Advocacy, Membership & Staying Informed 🤝 12:48 – Closing & What Comes Next 👋